From lab to patients: How to make the way Europe regulates medicines future-proof?

An interactive panel on how the historical rewrite of the EU pharma legislation and the new EU pharmaceutical strategy can embrace latest digital and medical scientific developments, and why we need a more innovative, fast and flexible regulatory framework.

Among the topics to be discussed:

• Which medical and digital technologies have the highest potential to transform healthcare in the next 10-20 years?  
• What will it take for Europe to become a true world leader in health and life science and innovation?
• Can Europe make the best use of real-world data and evidence in medicinal product development?
• How can Europe’s regulatory approach allow ground-breaking R&D and future technologies to flourish?

This session, organised in the context of the Science|Business Horizon Europe: The first assessment conference, features the launch of the new Future-Proofing Medicines initiative, a new pan-European, multistakeholder programme of high-level events and reports to explore the impact of cutting-edge scientific and health technology innovations on medicines regulation.